title: An attractive therapeutic target, mTOR pathway, in ALK+ anaplastic large cell lymphoma.
authors.affiliation: Department of Pathology, The Methodist Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: Jeong Hee
authors.initials: JH
authors.lastname: Cho-Vega
authors.forename: Francisco
authors.initials: F
authors.lastname: Vega
authors.forename: L Jeffrey
authors.initials: LJ
authors.lastname: Medeiros